Tdap Vaccine in Pregnancy

Tetanus, diphtheria, and acellular pertussis vaccine administered in every pregnancy to boost maternal antibody transfer to the foetus, protecting newborns from pertussis before they can be vaccinated.

The Tdap Vaccine in Pregnancy is recommended for 27–36 weeks of every pregnancy. It falls under the Pregnancy vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Tdap Vaccine in Pregnancy has an efficacy of 78–91% (neonatal protection). This means it provides significant protection against Pertussis (Whooping Cough) in Newborns and Tetanus. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain and redness at injection site; mild fever; fatigue. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Tdap Vaccine in Pregnancy should be avoided by: Severe allergy to a previous Tdap/DTaP dose; encephalopathy within 7 days of prior pertussis vaccination. Always inform your healthcare provider of your full medical history before vaccination.

The Tdap Vaccine in Pregnancy typically costs ₹800 – ₹2,000 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.